We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$9.69B
AUM Growth
+$805M
Cap. Flow
+$420M
Cap. Flow %
4.33%
Top 10 Hldgs %
28.55%
Holding
286
New
47
Increased
108
Reduced
76
Closed
36

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$93.3M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$64.9M
3
AMZN icon
Amazon
AMZN
+$58.3M
4
SYK icon
Stryker
SYK
+$56.3M
5
PRAH
PRA Health Sciences, Inc.
PRAH
+$49.9M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$77M
2
AMGN icon
Amgen
AMGN
+$72.2M
3
AET
Aetna Inc
AET
+$65.7M
4
CELG
Celgene Corp
CELG
+$54.3M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$52.8M

Sector Composition

Rank Sector Weight
1 Financials 21.51%
2 Healthcare 20.26%
3 Technology 19.08%
4 Communication Services 10.55%
5 Industrials 6.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MULE
176
DELISTED
MuleSoft, Inc.
MULE
$7.38M 0.08%
317,206
+192,106
+154% +$4.36M
USB icon
177
US Bancorp
USB
$99.6B
$7.2M 0.07%
134,356
-388
-0.3% -$20.9K
HON icon
178
Honeywell
HON
$77.1B
$7.07M 0.07%
+51,023
New +$6.84M
CASC
179
DELISTED
Cascadian Therapeutics, Inc.
CASC
$7.03M 0.07%
1,900,000
+650,000
+52% +$2.66M
ASMB icon
180
Assembly Biosciences
ASMB
$506M
$6.8M 0.07%
+12,525
New +$5.67M
CFG icon
181
Citizens Financial Group
CFG
$30.4B
$6.52M 0.07%
155,244
+125,188
+417% +$4.9M
AYX
182
DELISTED
Alteryx Inc
AYX
$6.42M 0.07%
253,954
+43,954
+21% +$1.06M
EBAY icon
183
eBay
EBAY
$48.6B
$6.29M 0.06%
166,576
-93,917
-36% -$3.49M
XYZ
184
Block Inc
XYZ
$45.9B
$6.28M 0.06%
181,313
-769,348
-81% -$28.2M
GLW icon
185
Corning
GLW
$126B
$6.17M 0.06%
+193,003
New +$6.08M
AERI
186
DELISTED
Aerie Pharmaceuticals
AERI
$5.97M 0.06%
+100,000
New +$6.06M
BKNG icon
187
Booking.com
BKNG
$138B
$5.87M 0.06%
84,475
-25,200
-23% -$1.83M
LFUS icon
188
Littelfuse
LFUS
$10.2B
$5.76M 0.06%
29,119
-12,075
-29% -$2.42M
DCPH
189
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$5.67M 0.06%
+250,000
New +$4.9M
CASH icon
190
Pathward Financial
CASH
$1.81B
$5.16M 0.05%
167,094
+822
+0.5% +$23.8K
RPD icon
191
Rapid7
RPD
$634M
$5.07M 0.05%
272,069
-94,510
-26% -$1.75M
AZPN
192
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$4.96M 0.05%
+74,988
New +$4.96M
TEAM icon
193
Atlassian
TEAM
$22B
$4.85M 0.05%
+106,640
New +$4.96M
SHPG
194
DELISTED
Shire pic
SHPG
$4.65M 0.05%
30,000
-20,000
-40% -$2.96M
SNPS icon
195
Synopsys
SNPS
$71.5B
$4.59M 0.05%
+53,885
New +$4.66M
MIXT
196
DELISTED
MIX TELEMATICS LIMITED
MIXT
$4.34M 0.04%
340,867
+95,413
+39% +$1.05M
EWBC icon
197
East-West Bancorp
EWBC
$17.9B
$4.32M 0.04%
71,027
– –
PTC icon
198
PTC
PTC
$13.7B
$4.22M 0.04%
+69,444
New +$4.31M
INCY icon
199
Incyte
INCY
$23.5B
$4.03M 0.04%
42,500
-5,000
-11% -$523K
ADSK icon
200
Autodesk
ADSK
$44.3B
$3.98M 0.04%
37,935
-13,500
-26% -$1.57M
6 7
8
9 10

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Polar Capital held 286 positions worth $9.69B, up 9.1% from $8.89B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Polar Capital deployed $420M of net new capital in Q4 2017, opening 47 new positions and adding to 108 existing holdings. Its largest new stake was Alnylam Pharmaceuticals: 516,232 shares worth $65.6M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Aetna Inc, an estimated $65.7M trimmed.

  • Polar Capital's largest Q4 2017 buy was Alnylam Pharmaceuticals: 516,232 shares worth $65.6M.
  • Polar Capital added most to Microsoft in Q4 2017, an estimated $93.3M increase.
  • Polar Capital's biggest Q4 2017 reduction was Aetna Inc, cutting an estimated $65.7M.
  • Polar Capital fully exited PepsiCo in Q4 2017, selling an estimated $77M.
  • Polar Capital's ten largest holdings make up 29% of its $9.69B portfolio in Q4 2017.
  • Polar Capital opened 47 new positions and closed 36 in Q4 2017.
  • Polar Capital's portfolio value rose 9.1% quarter-over-quarter to $9.69B.

Based on Polar Capital's 13F filing for Q4 2017, filed 14 Feb 2018.